Abstract
Arterial hypertension (AH) constitutes the main problem in primary medical practice in most industrialized countries. In England, in 1974, it generated five times more visits to the general practitioner than problems related to diabetes control.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Hypertension Detection and Follow-up Program Cooperative Group: The effect of treatment on mortality in ‘mild’ hypertension. N Engl J Med 1982; 307: 976–980.
Stamler R, Stamler J: ‘Mild’ hypertension: risks and strategy for control. Primary Cardiol 1983; 9: 150–166.
Lew EA: Blood pressure and mortality-life insurance experience. In: Stamler J, Stamler R, Pullman TN (eds) The epidemiology of hypertension. Grune and Stratton, New York, 1976.
Kannel WB, Gordon T: The Framingham study: an epidemiological investigation of cardiovascular disease. Section 26, Government Printing Office, Washington DC, 1970.
Kanner WB: Results of the epidemiologic investigation of ischaemic heart disease: illustrated by the Framingham Study. In: Hass JH, Hemker HC, Snellen HA (eds) Ischaemic heart disease. Leiden University Press, Leiden, 1970.
Sokolou M, Perloff D: The prognosis of essential hypertension treated conservatively. Circulation 1961; 23: 697.
Dauwer, TR, Kannel WB, Revostkie N, Kagan A: The epidemiology of coronary heart disease - The Framingham enquiry. Proc Royal Soc Med 1962; 55: 265.
Kannel WB: Assessment of hypertension as a predictor of cardiovascular disease: the Framingham Study. In: Burley DM, Birdwood GFB, Frya JH, Taylor SH (eds) Hypertension, its nature and treatment. CIBA Laboratories, Horscham, England, 1975.
Hines EA, Brown GE: A standard test for measuring the variability of the blood pressure: its significance as an index of the prehypertension state. Ann Intern Med, 1933; 7: 209.
Rabkin SW, Mathewson FAL, Tate RB: Long-term changes in blood pressure and risk of cerebrovascular disease. Stroke, 1978; 9: 319.
Taguchi J, Freis ED: Partial reduction of blood pressure and prevention of complications in hypertension. N Engl J Med, 1974; 291: 329.
Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. JAMA, 1970; 213: 1143–1152.
Wolf IW, Lindeman RD: Effects of treatment on hypertension results of a controlled study. Chron Dis, 1966; 19: 227.
Hamilton M, Thompson EN, Wisniewski TKM: The role of blood pressure control in preventing complications of hypertension. Lancet, 1964; 1: 235.
Smith WMcF: Intervention trial in mild hypertension. Cooperative Study Group. Public Health Service Hospitals. Circulation, 1976; 95 (Suppl II): 95.
Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension III. Influence of age, diastolic pressure, and prior cardiovascular disease. Further analysis of side effects. Circulation, 1972; 45: 991–1004.
Breckenridge A, Dollery CT, Parry EH: Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. A J Med 1970; 39: 411.
Amsterdam EA, Wolfson S, Gorlin R: Effect of therapy on survival in angina pectoris. Ann Intern Med, 1968; 68: 1151.
Berglund G, Wilhelmsen L, Sannerstedt R, Hansson L, Anderson O, Sivertsson R, Wedel H, Wikstrand J: Coronary heart disease after treatment of hypertension. Lancet, 1978; 1: 1.
Williams EMVM, Raine AEG: Effect of prolonged ß-receptor blockade on dry weight and electrophysiological responses of rapid heart. Lancet, 1974; 2: 1048.
Williams EM, Tasgal J, Raine AEG: Morphometric changes in rabbit ventricular myocardium produced by long-term ß-adrenoreceptor blockade. Lancet, 1977; 2: 850.
Lewis PJ, Kohner EM, Petrie A, Dollery CT: Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment. Lancet, 1976; 1: 564.
Ames R, Hill P: Increase in serum lipids during treatment of hypertension with chlorothalidone. Lancet, 1976; 1: 721.
Schander H, Fitz A, Frohlich E, Goldman A, Perry HM, Steele B: Chlorthalidone and serum cholesterol. Lancet, 1977; 2: 295.
Walker WJ: Changing United life-style and declining vascular mortality: cause or co-in- cidence? N Engl J Med, 1977; 297: 163.
Dawber TR, Kannel WB, McNamara PM: The prediction of coronary heart disease. Transactions of the Association of Life Insurance Medical Divisions of America, 1964; 47: 70.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Abadal, L.T. (1988). The Value of Treatment in the Prevention of Hypertension Complications. In: de Luna, A.B., Betriu, A., Permanyer, G. (eds) Therapeutics in Cardiology. Developments in Cardiovascular Medicine, vol 81. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1333-2_26
Download citation
DOI: https://doi.org/10.1007/978-94-009-1333-2_26
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7094-2
Online ISBN: 978-94-009-1333-2
eBook Packages: Springer Book Archive